サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：薬物乱用治療市場、シェア、規模、動向、産業分析レポート、治療タイプ別（薬物乱用、アルコール、タバコ/ニコチン、その他）、最終用途別、地域別、セグメント別予測、2023年～2032年
市場調査レポート
商品コード
1297968

薬物乱用治療市場、シェア、規模、動向、産業分析レポート、治療タイプ別（薬物乱用、アルコール、タバコ/ニコチン、その他）、最終用途別、地域別、セグメント別予測、2023年～2032年

Substance Abuse Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drug Abuse, Alcohol, Tobacco/Nicotine, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
薬物乱用治療市場、シェア、規模、動向、産業分析レポート、治療タイプ別（薬物乱用、アルコール、タバコ/ニコチン、その他）、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年05月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の薬物乱用治療市場規模は2032年までに220億1,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

効果的で手ごろな価格の薬物乱用治療への需要が高まるにつれ、ヘルスケア業界は新しく革新的な中毒治療法の開発に努めています。これは、この分野における研究開発活動の活発化に反映されています。例えば、米国の国立薬物乱用研究所（NIDA）は、新たな治療法の開発研究を含む依存症研究に13億米ドル以上を費やしています。

さらに、薬物乱用に対する世界の関心から、その悪影響や予防に対する人々の意識を高める取り組みも活発化しています。世界保健機関（WHO）によると、世界中で約3,500万人が薬物使用障害に苦しんでいます。この憂慮すべき統計により、世界中で依存症治療センターの数が増加しています。

薬物治療は、薬物依存症の人が強迫的な薬物使用や依存行動をやめるのを支援することを目的としています。治療は様々な環境で、様々な方法を用いて行われ、期間も様々です。薬物依存症は慢性的な症状であり、しばしば再発を繰り返すため、短期間または1回限りの治療では不十分なことが多いです。治療には、頻繁なモニタリングと複数回の介入が必要で、長期にわたることもあります。

エビデンスに基づく治療アプローチへの需要が高まり、薬物補助療法や行動療法などの新しい治療法や治療オプションが開発されています。また、依存症は専門的な治療を必要とする医学的疾患であるという認識が広まりつつあり、その結果、懲罰的なアプローチから、より思いやりのあるエビデンスに基づく戦略への転換が進んでいます。さらに、薬物乱用障害、特にオピオイド中毒の有病率の上昇と、COVID-19の流行中に普及した遠隔医療サービスやバーチャル治療の選択肢を含む薬物乱用治療センターや施設の利用可能性の増加が市場を牽引しています。

薬物乱用治療市場レポートハイライト

  • 薬物乱用分野は、予測期間内に世界市場を独占すると予想されます。薬物乱用は、心臓、腎臓、肝臓の損傷などの身体部分に害を及ぼし、行動パターンの変化、幻覚、記憶喪失を引き起こす可能性があるからです。それが中毒治療につながります。
  • 病院セグメントが最大の市場シェアを占め、予測期間中市場を独占します。薬物乱用の重症例は、必要な中毒治療を提供するために病院に連れて行く必要があります。
  • 北米は、薬物乱用障害の有病率の上昇、認知度の向上、同地域の成長を推進する政府のイニシアチブの高まりにより、予測期間中に最も高いCAGRで成長すると予測されます。
  • 世界の主要市場企業は以下の通り：INSYS Therapeutics、Teva Pharmaceutical、Sun Pharma、Glenmark、Sanofi Aventis、Sterinova、Apotex、BioCorRx、Opiant Technologies、Accord Healthcare、Mylan Laboratories、Cipla、LFB Group、Lupin、Amphastar Pharmaceuticals、Sanquin。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の薬物乱用治療市場に関する洞察

  • 薬物乱用治療市場- 業界スナップショット
  • 薬物乱用治療市場力学
    • 促進要因と機会
      • 依存症人口の増加
      • 薬物啓発キャンペーンと予防プログラムの向上
    • 抑制要因と課題
      • 依存症の再発につながる治療の中止
  • PESTLE分析
  • 薬物乱用治療業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の薬物乱用治療市場、治療タイプ別

  • 主な調査結果
  • イントロダクション
  • 薬物乱用
  • アルコール
  • タバコ/ニコチン
  • その他

第6章 世界の薬物乱用治療市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • リハビリテーションセンター
  • その他

第7章 世界の薬物乱用治療市場、地域

  • 主な調査結果
  • イントロダクション
    • 薬物乱用治療市場評価、地域別、2019-2032年
  • 薬物乱用治療市場-北米
    • 北米：薬物乱用治療市場、最終用途別、2019～2032年
    • 北米：薬物乱用治療市場、治療タイプ別、2019～2032年
    • 薬物乱用治療市場-米国
    • 薬物乱用治療市場- カナダ
  • 薬物乱用治療市場- 欧州
    • 欧州：薬物乱用治療市場、最終用途別、2019～2032年
    • 欧州：薬物乱用治療市場、治療タイプ別、2019～2032年
    • 薬物乱用治療市場- 英国
    • 薬物乱用治療市場- フランス
    • 薬物乱用治療市場- ドイツ
    • 薬物乱用治療市場- イタリア
    • 薬物乱用治療市場- スペイン
    • 薬物乱用治療市場- オランダ
    • 薬物乱用治療市場- ロシア
  • 薬物乱用治療市場- アジア太平洋
    • アジア太平洋：薬物乱用治療市場、最終用途別、2019～2032年
    • アジア太平洋：薬物乱用治療市場、治療タイプ別、2019～2032年
    • 薬物乱用治療市場- 中国
    • 薬物乱用治療市場- インド
    • 薬物乱用治療市場- マレーシア
    • 薬物乱用治療市場- 日本
    • 薬物乱用治療市場- インドネシア
    • 薬物乱用治療市場- 韓国
  • 薬物乱用治療市場-中東およびアフリカ
    • 中東およびアフリカ：薬物乱用治療市場、最終用途別、2019～2032年
    • 中東およびアフリカ：薬物乱用治療市場、治療タイプ別、2019～2032年
    • 薬物乱用治療市場- サウジアラビア
    • 薬物乱用治療市場-UAE
    • 薬物乱用治療市場- イスラエル
    • 薬物乱用治療市場- 南アフリカ
  • 薬物乱用治療市場-ラテンアメリカ
    • ラテンアメリカ：薬物乱用治療市場、最終用途別、2019～2032年
    • ラテンアメリカ：薬物乱用治療市場、治療タイプ別、2019～2032年
    • 薬物乱用治療市場- メキシコ
    • 薬物乱用治療市場- ブラジル
    • 薬物乱用治療市場- アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • INSYS Therapeutics
  • Teva Pharmaceutical
  • Sun Pharma
  • Glenmark
  • Sanofi Aventis
  • Sterinova
  • Apotex
  • BioCorRx
  • Opiant Technologies
  • Accord Healthcare
  • Mylan Laboratories
  • Cipla
  • LFB Group
  • Lupin
  • Amphastar Pharmaceuticals
  • Sanquin
図表

List of Tables

  • Table 1 Global Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 2 Global Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 3 Substance Abuse Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 5 North America: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 12 UK: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 13 UK: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 14 France: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 France: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 28 China: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 China: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 30 India: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 31 India: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Substance Abuse Treatment Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End-Use
  • Figure 7 Global Substance Abuse Treatment Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment Type
  • Figure 9 Global Substance Abuse Treatment Market, by Treatment Type, 2022 & 2032 (USD Billion)
  • Figure 10 Substance Abuse Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Substance Abuse Treatment Market
目次
Product Code: PM3217

The global substance abuse treatment market size is expected to reach USD 22.01 billion by 2032, according to a new study by Polaris Market Research. The report "Substance Abuse Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drug Abuse, Alcohol, Tobacco/Nicotine, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

As the demand for effective and affordable substance abuse treatments grows, the healthcare industry strives to develop new and innovative addiction treatment therapies. This is reflected in the increasing research and development activities in this field. For instance, the National Institute on Drug Abuse (NIDA) in the U.S. spent over $1.3 billion on addiction research, including studies on developing new treatments.

In addition, the global concern for substance abuse has led to increased efforts to raise awareness about its ill effects and prevention among people. According to the World Health Organization (WHO), around 35 million people worldwide suffer from drug use disorders. This alarming statistic has led to a rise in the number of addiction treatment centers across the globe.

Drug treatment aims to assist individuals with addiction in ceasing compulsive drug use and addictive behaviors. Treatment can be provided in various environments, using diverse modalities, and may vary in duration. As drug addiction is a chronic condition often marked by occasional relapses, short-term or one-time treatment is often insufficient. Sometimes, treatment is a lengthy process requiring frequent monitoring and multiple interventions.

There is an increasing demand for evidence-based treatment approaches, leading to the development of new therapies and treatment options, such as medication-assisted treatment and behavioral therapies. There is also a growing acceptance of addiction as a medical condition requiring specialized treatment, resulting in a shift from punitive approaches to more compassionate and evidence-based strategies. Additionally, the market has been driven by the rising prevalence of substance abuse disorders, particularly opioid addiction, and the increasing availability of substance abuse treatment centers and facilities, including telehealth services and virtual treatment options that have become popular during the COVID-19 pandemic.

Substance Abuse Treatment Market Report Highlights

  • Drug abuse segment is expected to dominate the global market within the projected period. Because drug abuse can harm the body parts such as heart, kidney, and liver damage, and may change behavior patterns, hallucinations, and memory loss. Which leads to addiction therapy.
  • Hospital segment holds the largest market share and will dominate the market over the projected period. Severe cases of drug abuse need to take to the hospital to provide necessary addiction treatment.
  • North America is anticipated to grow at the highest CAGR during the projected period, due to raising the prevalence of substance abuse disorders, increasing awareness, and growing government initiatives that propel the region's growth.
  • The global key market players include: INSYS Therapeutics, Teva Pharmaceutical, Sun Pharma, Glenmark, Sanofi Aventis, Sterinova, Apotex, BioCorRx, Opiant Technologies, Accord Healthcare, Mylan Laboratories, Cipla, LFB Group, Lupin, Amphastar Pharmaceuticals, and Sanquin.

Polaris Market Research has segmented the substance abuse treatment market report based on treatment type, end-use, and region:

Substance Abuse Treatment, Treatment Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Drug Abuse
  • Alcohol
  • Tobacco/Nicotine
  • Others

Substance Abuse Treatment, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Others

Substance Abuse Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Substance Abuse Treatment Market Insights

  • 4.1. Substance Abuse Treatment Market - Industry Snapshot
  • 4.2. Substance Abuse Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Number Of Addicted Population
      • 4.2.1.2. Rising Drug Awareness Campaigns And Prevention Programs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Discontinuation Of Therapies Leading To Relapse Of Addiction
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Substance Abuse Treatment Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Substance Abuse Treatment Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Substance Abuse Treatment, by Treatment Type, 2019-2032 (USD Billion)
  • 5.3. Drug Abuse
    • 5.3.1. Global Substance Abuse Treatment Market, by Drug Abuse, by Region, 2019-2032 (USD Billion)
  • 5.4. Alcohol
    • 5.4.1. Global Substance Abuse Treatment Market, by Alcohol, by Region, 2019-2032 (USD Billion)
  • 5.5. Tobacco/Nicotine
    • 5.5.1. Global Substance Abuse Treatment Market, by Tobacco/Nicotine, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Substance Abuse Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Substance Abuse Treatment Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Substance Abuse Treatment Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 6.4. Clinics
    • 6.4.1. Global Substance Abuse Treatment Market, by Clinics, by Region, 2019-2032 (USD Billion)
  • 6.5. Rehabilitation Centres
    • 6.5.1. Global Substance Abuse Treatment Market, by Rehabilitation Centres, by Region, 2019-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Substance Abuse Treatment Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Substance Abuse Treatment Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Substance Abuse Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Substance Abuse Treatment Market - North America
    • 7.3.1. North America: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.3. Substance Abuse Treatment Market - U.S.
      • 7.3.3.1. U.S.: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.3.4. Substance Abuse Treatment Market - Canada
      • 7.3.4.1. Canada: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.4. Substance Abuse Treatment Market - Europe
    • 7.4.1. Europe: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.3. Substance Abuse Treatment Market - UK
      • 7.4.3.1. UK: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.4. Substance Abuse Treatment Market - France
      • 7.4.4.1. France: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.5. Substance Abuse Treatment Market - Germany
      • 7.4.5.1. Germany: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.6. Substance Abuse Treatment Market - Italy
      • 7.4.6.1. Italy: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.7. Substance Abuse Treatment Market - Spain
      • 7.4.7.1. Spain: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.8. Substance Abuse Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.4.9. Substance Abuse Treatment Market - Russia
      • 7.4.9.1. Russia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.5. Substance Abuse Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.3. Substance Abuse Treatment Market - China
      • 7.5.3.1. China: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.4. Substance Abuse Treatment Market - India
      • 7.5.4.1. India: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.5. Substance Abuse Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.6. Substance Abuse Treatment Market - Japan
      • 7.5.6.1. Japan: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.7. Substance Abuse Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.5.8. Substance Abuse Treatment Market - South Korea
      • 7.5.8.1. South Korea: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.6. Substance Abuse Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.3. Substance Abuse Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.4. Substance Abuse Treatment Market - UAE
      • 7.6.4.1. UAE: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.5. Substance Abuse Treatment Market - Israel
      • 7.6.5.1. Israel: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.6.6. Substance Abuse Treatment Market - South Africa
      • 7.6.6.1. South Africa: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
  • 7.7. Substance Abuse Treatment Market - Latin America
    • 7.7.1. Latin America: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.3. Substance Abuse Treatment Market - Mexico
      • 7.7.3.1. Mexico: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.4. Substance Abuse Treatment Market - Brazil
      • 7.7.4.1. Brazil: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)
    • 7.7.5. Substance Abuse Treatment Market - Argentina
      • 7.7.5.1. Argentina: Substance Abuse Treatment Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Substance Abuse Treatment Market, by Treatment Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. INSYS Therapeutics
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Teva Pharmaceutical
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Sun Pharma
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Glenmark
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Sanofi Aventis
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Sterinova
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Apotex
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. BioCorRx
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Opiant Technologies
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Accord Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Mylan Laboratories
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Cipla
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. LFB Group
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Lupin
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Amphastar Pharmaceuticals
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Sanquin
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development